Chemoinformaics analysis of Gamatin
Molecular Weight | 336.299 | nRot | 2 |
Heavy Atom Molecular Weight | 324.203 | nRig | 26 |
Exact Molecular Weight | 336.063 | nRing | 5 |
Solubility: LogS | -5.392 | nHRing | 3 |
Solubility: LogP | 4.049 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 19 |
No. of Oxygen atom | 6 | No. of Arom Bond | 21 |
nHA | 6 | APOL | 44.5435 |
nHD | 0 | BPOL | 21.5865 |
QED | 0.552 |
Synth | 2.627 |
Natural Product Likeliness | 1.09 |
NR-PPAR-gamma | 0.157 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.081 |
Pgp-sub | 0.003 |
HIA | 0.002 |
CACO-2 | -4.829 |
MDCK | 0.0000571 |
BBB | 0.015 |
PPB | 0.935555 |
VDSS | 0.402 |
FU | 0.0651194 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.249 |
CYP2c19-inh | 0.97 |
CYP2c19-sub | 0.065 |
CYP2c9-inh | 0.808 |
CYP2c9-sub | 0.926 |
CYP2d6-inh | 0.903 |
CYP2d6-sub | 0.919 |
CYP3a4-inh | 0.897 |
CYP3a4-sub | 0.135 |
CL | 9.326 |
T12 | 0.158 |
hERG | 0.138 |
Ames | 0.055 |
ROA | 0.225 |
SkinSen | 0.301 |
Carcinogencity | 0.872 |
EI | 0.389 |
Respiratory | 0.793 |
NR-Aromatase | 0.653 |
Antiviral | Yes |
Prediction | 0.68793 |